Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomolecules Involved in Both Metastasis and Placenta Accreta Spectrum-Does the Common Pathophysiological Pathway Exist? | Cancers (Basel) | 2023 | 37174083 | PubTator, text mining | PubMed |
| Genetic considerations in cerebral small vessel diseases. | Front Neurol | 2023 | 37168667 | PubTator, text mining | PubMed |
| Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA. | Cell Syst | 2023 | 37164011 | PubTator, text mining | PubMed |
| The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness. | Proc Natl Acad Sci U S A | 2023 | 37155842 | PubTator, text mining | PubMed |
| Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity. | Sci Adv | 2023 | 37126556 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma. | Front Oncol | 2023 | 37124494 | PubTator, text mining | PubMed |
| Coexistence of junctional epidermolysis bullosa, autosomal recessive deafness type 57, and Angelman syndrome: A case report. | Clin Case Rep | 2023 | 37113642 | PubTator, text mining | PubMed |
| A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance. | Int J Mol Sci | 2023 | 37108401 | PubTator, text mining | PubMed |
| Expanded directly binds conserved regions of Fat to restrain growth via the Hippo pathway. | J Cell Biol | 2023 | 37071483 | PubTator, text mining | PubMed |
| An Overview of Angiogenesis in Bladder Cancer. | Curr Oncol Rep | 2023 | 37052868 | PubTator, text mining | PubMed |
| POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 37047824 | PubTator, text mining | PubMed |
| Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct. | Nat Commun | 2023 | 37045813 | PubTator, text mining | PubMed |
| Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1. | Cell Death Dis | 2023 | 37037818 | PubTator, text mining | PubMed |
| The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy. | Mol Cancer | 2023 | 37024932 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Comparison of Genetic Profiles of Neonates in Intensive Care Units Conceived With or Without Assisted Reproductive Technology. | JAMA Netw Open | 2023 | 37014641 | PubTator, text mining | PubMed |
| A novel inflammation-related signature for predicting prognosis and characterizing the tumor microenvironment in colorectal cancer. | Aging (Albany NY) | 2023 | 37014331 | PubTator, text mining | PubMed |
| Editorial: Autoimmune blistering diseases, volume II. | Front Immunol | 2023 | 37006261 | PubTator, text mining | PubMed |
| Influence of Surface Characteristics of TiO2 Coatings on the Response of Gingival Cells: A Systematic Review of In Vitro Studies. | Materials (Basel) | 2023 | 36984413 | PubTator, text mining | PubMed |
| Transcriptomic Studies on Intracranial Aneurysms. | Genes (Basel) | 2023 | 36980884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=15